Advaxis Study in Head and Neck Cancer Selected for Late-Breaking Poster at the American Association for Cancer ... - Nasdaq

Proactive Investors USA & Canada

Advaxis Study in Head and Neck Cancer Selected for Late-Breaking Poster at the American Association for Cancer ... Nasdaq More than 90 percent of head and neck squamous cell oropharyngeal cancers originate from the mucosal linings of the oral cavity, pharynx, or larynx. Currently, 60 to 80 percent of these cancers are caused by HPV. Head and neck cancers are treated by ... Advaxis to present 'remarkable progress' at cancer conferenceProactive Investors USA & Canada all 11 news articles »

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1Y8Qkjo
via IFTTT